BIIB - Biogen Idec Inc.

BIIB valuation $91.90 billion

Stock Price

389.16
Change: ↑ 35.91 (10.1656%)
Last Update: 2015-01-30T16:15:14-05:00
Shares Outstanding: 236,155,407
Industry: Biotechnology
Website Investor Relations

Biogen Idec is an American company known for its work in the field of biotechnology. The company develops therapies for neurological and autoimmune disorders as well as cancer. Biogen Idec is also classed as a Fortune 500 company with yearly revenues in excess of $5 billion. It was formed in 2003 when two companies Biogen Inc. and IDEC pharmaceuticals merged. The organization has its offices in over 30 countries and it also maintains distribution agreements in more than 60 countries.

The organization has manufacturing plants in Kendall Square and Research Triangle Park in North Carolina. Outside the country, they have a large scale manufacturing facility in Denmark. The company’s research and development departments are located at Cambridge, Massachusetts. Biogen’s prime competitors include Novartis, Teva, Sanofi Aventis and Bayer Schering Pharma, which are also among the industry leaders.

Some of the most famous products developed by the company include Avonex, Tysabri and Rituxan which are used to treat multiple sclerosis, Crohn’s disease and non-Hodgkin lymphoma, respectively. A few years ago the company started a subsidiary organization called the Biogen Iden Foundation. This social welfare organization focuses on improving lives by spreading scientific knowledge. Presently, Biogen Idec, Inc. has over 5,000 employees working globally.

Stock Price Data

Open: 372.75 Previous Close: 353.25
High: 397.00 Low: 372.75
Bid: 385.00 Ask: 389.50

Bid Size: 100 Ask Size: 100
Raw Bid Size: 1 Raw Ask Size: 1
Trade Volume: 40435 Share Volume: 3920693
Last Trade Date: 2015-01-30 Last Trade Time: 16:15:03-05:00
Vwap: 390.270661 EPS: 10.56

Fundamental Data

PE ratio: 33.90 PB ratio: 8.812
Beta: 1.101713

52 Week High: 366.17 52 Week Low: 272.02
52 Week High Vwap: 361.9816 52 Week Low Vwap: 279.5002
52 Week High Volume: 7071216 52 Week Low Volume: 637122
52 Week Avg Volume: 1492622
* Quotes delayed 15 minutes

Related Stocks

StockCompany namePrice
GILD Gilead Sciences Inc. 104.83
IMGN ImmunoGen Inc. 7.63
CELG Celgene Corporation 119.10
ARNA Arena Pharmaceuticals Inc. 4.31
MNKD MannKind Corporation 6.35
AMGN Amgen Inc 152.26
NVAX Novavax Inc. 7.81
NPSP NPS Pharmaceuticals Inc. 45.86
ARIA ARIAD Pharmaceuticals Inc. 6.45
PDLI PDL BioPharma Inc. 7.29